C.I. Medical Co.,Ltd.
3540.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -1.16 | -1.90 | -4.80 |
| FCF Yield | 10.73% | -21.64% | -15.69% | -2.70% |
| EV / EBITDA | 6.65 | 14.33 | 13.16 | 8.77 |
| Quality | ||||
| ROIC | 4.48% | 5.22% | 10.14% | 18.16% |
| Gross Margin | 31.54% | 26.29% | 27.22% | 28.16% |
| Cash Conversion Ratio | 0.98 | -0.07 | 0.56 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.31% | 3.46% | 4.68% | 12.73% |
| Free Cash Flow Growth | 154.25% | -14.45% | -533.60% | -133.86% |
| Safety | ||||
| Net Debt / EBITDA | 1.80 | 3.86 | 1.26 | -0.75 |
| Interest Coverage | 40.87 | 175.82 | 665.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 2.96 | 3.92 | 4.32 | 4.80 |
| Cash Conversion Cycle | 104.75 | 128.01 | 101.59 | 91.51 |